Tactile Systems Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
February 20, 2024 at 06:25 pm IST
Share
Tactile Systems Technology, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 274.42 million compared to USD 246.79 million a year ago. Revenue was USD 274.42 million compared to USD 246.79 million a year ago.
Net income was USD 28.52 million compared to net loss of USD 17.87 million a year ago. Basic earnings per share from continuing operations was USD 1.24 compared to basic loss per share from continuing operations of USD 0.89 a year ago. Diluted earnings per share from continuing operations was USD 1.23 compared to diluted loss per share from continuing operations of USD 0.89 a year ago.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.